SCHEMBL6856412

SCHEMBL6856412

COc1ccc(N(c2nc(N)nc(NCCN3CCCCC3)n2)C2CCCCCC2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPIN1 Q9Y657 2/20 0.40
KMT5A Q9NQR1 3/20 0.39
HTR1A P08908 3/20 0.39
DRD2 P14416 3/20 0.39
HTR2A P28223 3/20 0.39
HTR7 P34969 3/20 0.39
HTR6 P50406 3/20 0.39
P2RX3 P56373 1/20 0.37
P2RX2 Q9UBL9 1/20 0.37
HTR2C P28335 1/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818739 0.83 SMN1; SMN2 (0.46) LMNASMN1; SMN2KDM4EHPGDALDH1A1
SCHEMBL5032272 0.81 SMN1; SMN2 (0.48) LMNASMN1; SMN2KDM4EHPGDALDH1A1
SCHEMBL6233712 0.79 ALDH1A1 (0.39) HTR1ADRD2HTR2AHTR7HTR6
SCHEMBL6237774 0.78 EHMT2 (0.45) SPIN1KMT5AHTR1ADRD2HTR2A
SCHEMBL4841050 0.78 SMN1; SMN2 (0.39) LMNAPOLBTSHRSMN1; SMN2L3MBTL1
SCHEMBL5438494 0.77 SMN1; SMN2 (0.45) LMNASMN1; SMN2KDM4EHPGDALDH1A1
SCHEMBL6863012 0.73 SLC6A2 (0.34) SPIN1KMT5ASMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL5424915 0.72 EHMT2 (0.39) KMT5AHTR2AEHMT2GALR1
SCHEMBL4832691 0.71 GALR1 (0.49) NPSR1SMN1; SMN2HPGDKDM1AEHMT2
SCHEMBL6916172 0.71 LMNA (0.43) LMNAPOLBALOX15TSHRCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040077648-A1 Methods and compositions of novel triazine compounds DR. REDDY'S LABORATORIES LTD. (IN) 2004-04-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077648-A1 Methods and compositions of novel triazine compounds AREG, TGFB1, PTGIS SPIN1 4353/4885KMT5A 2890/4885HTR1A 3602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.